Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 30 04:00PM ET
81.28
Dollar change
+0.88
Percentage change
1.09
%
Index- P/E- EPS (ttm)-7.83 Insider Own5.70% Shs Outstand93.55M Perf Week-2.97%
Market Cap7.60B Forward P/E31.73 EPS next Y2.56 Insider Trans2.47% Shs Float88.21M Perf Month20.75%
Income-690.88M PEG- EPS next Q-0.28 Inst Own88.31% Short Float / Ratio4.82% / 2.83 Perf Quarter-32.83%
Sales1.10B P/S6.88 EPS this Y15.52% Inst Trans6.35% Short Interest4.25M Perf Half Y-34.60%
Book/sh8.17 P/B9.95 EPS next Y137.76% ROA-22.05% Target Price139.22 Perf Year-31.19%
Cash/sh18.53 P/C4.39 EPS next 5Y- ROE-115.61% 52W Range55.25 - 159.89 Perf YTD-37.27%
Dividend- P/FCF- EPS past 5Y-56.35% ROI-32.35% 52W High-49.17% Beta1.01
Dividend %- Quick Ratio4.90 Sales past 5Y45.19% Gross Margin83.66% 52W Low47.11% ATR4.00
Employees1162 Current Ratio5.44 Sales Q/Q44.10% Oper. Margin-36.13% RSI (14)36.77 Volatility2.64% 4.26%
OptionableYes Debt/Eq1.79 EPS Q/Q84.34% Profit Margin-62.52% Rel Volume0.84 Prev Close80.40
ShortableYes LT Debt/Eq1.79 EarningsNov 01 AMC Payout- Avg Volume1.50M Price81.28
Recom1.60 SMA20-0.03% SMA50-20.22% SMA200-31.44% Volume1,269,515 Change1.09%
Date Action Analyst Rating Change Price Target Change
Nov-21-23Initiated Wedbush Outperform $224
Oct-31-23Downgrade Oppenheimer Outperform → Perform
Oct-31-23Downgrade Cantor Fitzgerald Overweight → Neutral $166 → $40
Jun-23-23Downgrade Evercore ISI Outperform → In-line $139
Apr-26-23Initiated SMBC Nikko Outperform $185
Apr-04-23Initiated Citigroup Buy $179
Mar-01-23Upgrade Morgan Stanley Equal-Weight → Overweight $141 → $187
Dec-22-22Reiterated BTIG Research Buy $125 → $160
Dec-16-22Upgrade UBS Neutral → Buy $100 → $158
Apr-04-22Resumed Cantor Fitzgerald Overweight $140
Today 06:34PM
Nov-29-23 09:55AM
Nov-27-23 09:50AM
Nov-24-23 10:26AM
Nov-18-23 06:49AM
06:35AM Loading…
Nov-16-23 06:35AM
Nov-13-23 09:55AM
07:57AM
Nov-10-23 12:58AM
Nov-09-23 10:00AM
Nov-08-23 10:15AM
Nov-07-23 11:23PM
Nov-02-23 06:25PM
12:18PM
08:30AM
12:00AM Loading…
12:00AM
Nov-01-23 05:03PM
04:29PM
04:05PM
Oct-31-23 07:02PM
04:19PM
04:07PM
03:03PM
11:52AM
10:26AM
10:21AM
09:38AM
09:19AM
08:01AM
07:51AM
07:19AM Loading…
07:19AM
Oct-30-23 04:28PM
04:10PM
04:01PM
Oct-26-23 10:02AM
Oct-25-23 10:02AM
08:30AM
Oct-18-23 11:13AM
Oct-17-23 11:47AM
11:30AM
Oct-09-23 10:41AM
09:55AM
09:49AM
Sep-29-23 06:30PM
Sep-15-23 12:50PM
08:37AM
Sep-14-23 10:07AM
Sep-07-23 09:00AM
Sep-05-23 08:30AM
Sep-01-23 11:31AM
Aug-31-23 06:15PM
Aug-30-23 11:09AM
08:40AM
Aug-27-23 07:20PM
Aug-23-23 01:00PM
Aug-22-23 10:00AM
Aug-13-23 08:08AM
Aug-04-23 03:22PM
Aug-03-23 11:28AM
Aug-02-23 09:00PM
06:15PM
05:08PM
04:05PM
Jul-31-23 06:08PM
Jul-29-23 11:39AM
Jul-27-23 07:30AM
Jul-26-23 10:02AM
08:30AM
Jul-25-23 10:01AM
Jul-16-23 08:20AM
Jul-12-23 05:33PM
Jul-05-23 08:30AM
Jul-03-23 08:30AM
Jun-30-23 06:20PM
08:45AM
Jun-29-23 09:02AM
Jun-23-23 04:07PM
Jun-22-23 05:17PM
04:02PM
03:02PM
02:24PM
02:23PM
02:08PM
02:02PM
Jun-17-23 09:45AM
Jun-12-23 09:30AM
Jun-08-23 11:30AM
Jun-01-23 11:31AM
10:04AM
06:45AM
May-31-23 06:16PM
May-24-23 04:04PM
01:53PM
12:28PM
09:53AM
08:24AM
08:07AM
08:00AM
May-16-23 03:42PM
08:30AM
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BEHRENS M KATHLEENDirectorNov 03Option Exercise29.0315,000435,450174,993Nov 06 08:00 AM
Barry RichardDirectorNov 03Buy78.8150,0003,940,500140,000Nov 06 08:00 AM
INGRAM DOUGLAS SPresident & CEONov 03Buy79.3625,2252,001,800390,307Nov 06 08:00 AM
Chambers Michael AndrewDirectorAug 14Buy109.479,9791,092,429246,996Aug 15 08:00 AM
Chambers Michael AndrewDirectorAug 11Buy108.0523,6862,559,272237,017Aug 14 08:00 AM
Chambers Michael AndrewDirectorAug 10Buy106.1534,8673,701,067213,331Aug 11 07:40 AM
Wigzell Hans Lennart RudolfDirectorAug 04Option Exercise29.0315,000435,45035,994Aug 08 08:00 PM
Wigzell Hans Lennart RudolfDirectorAug 04Sale106.7215,0001,600,80020,994Aug 08 08:00 PM
BEHRENS M KATHLEENDirectorDec 19Option Exercise34.9220,000698,400158,470Dec 21 09:05 AM